Ghent, Flanders, Belgium · On-site
Senior Technician Application Deadline: 31 August 2026 Department: Research & Development Employment Type: Permanent - Full Time Location: Ghent Reporting To: Associate Director Description ATB Therapeutics is a Biotech …
Skills: Cell culture, Flow cytometry, ELISA, Luminex, High content imaging
Sign up with Clera and we'll reach out the moment a role actually fits you — no more spraying applications into the void.
The Senior Technician will execute experiments, analyze data, and support the development of new assays within the Cell Biology team. Additionally, they will assist the Laboratory Manager with lab setup, safety oversight, and the maintenance of technical documentation.
Candidates must hold a Bachelor or Master degree in a scientific field with at least 5 years of relevant industry or academic experience. Proficiency in cell culture, cell-based assays, and flow cytometry is required, along with strong communication and organizational skills.
Application Deadline: 31 August 2026
Department: Research & Development
Employment Type: Permanent - Full Time
Location: Ghent
Reporting To: Associate Director
Antibody Targeted Biologics
atbtherapeutics is a pioneering biopharmaceutical company building a new line of attack against cancer. atbtherapeutics has developed the atbody; a game-changer biologic format designed to broaden the therapeutic window of antibody-based therapies. Only our proprietary and versatile plant-based atbiofarm technology enables single-step manufacturing of our novel class of therapeutic atbodies. The resulting therapeutics offer a novel mechanism of action, avoiding major cancer cell resistance, and provide a promising, life-changing therapy for hard-to-treat and refractory cancer.
Offices: Rue de la Science 7, Aye, Luxembourg 6900, BE · Suzanne Tassierstraat 1, Ghent, East Flanders 9052, BE
Antibody Targeted Biologics
atbtherapeutics is a pioneering biopharmaceutical company building a new line of attack against cancer. atbtherapeutics has developed the atbody; a game-changer biologic format designed to broaden the therapeutic window of antibody-based therapies. Only our proprietary and versatile plant-based atbiofarm technology enables single-step manufacturing of our novel class of therapeutic atbodies. The resulting therapeutics offer a novel mechanism of action, avoiding major cancer cell resistance, and provide a promising, life-changing therapy for hard-to-treat and refractory cancer.
Offices: Rue de la Science 7, Aye, Luxembourg 6900, BE · Suzanne Tassierstraat 1, Ghent, East Flanders 9052, BE
